White-matter abnormalities in presymptomatic GRN and C9orf72 mutation carriers

被引:3
|
作者
Lee, Hyunwoo [1 ]
Mackenzie, Ian R. A. [2 ]
Beg, Mirza Faisal [3 ]
Popuri, Karteek [4 ]
Rademakers, Rosa [5 ,6 ,7 ]
Wittenberg, Dana [1 ]
Hsiung, Ging-Yuek Robin [1 ]
机构
[1] Univ British Columbia, Dept Med, Div Neurol, Vancouver, BC V6T 2B5, Canada
[2] Univ British Columbia, Fac Med, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada
[3] Simon Fraser Univ, Sch Engn Sci, Burnaby, BC V5A 1S6, Canada
[4] Mem Univ Newfoundland, Dept Comp Sci, St John, NL A1B 3X5, Canada
[5] VIB, VIB Ctr Mol Neurol, Appl & Translat Neurogen, B-2610 Antwerp, Belgium
[6] Univ Antwerp, Dept Biomed Sci, B-2610 Antwerp, Belgium
[7] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA
关键词
frontotemporal dementia; MRI; white matter; GENETIC FRONTOTEMPORAL DEMENTIA; HUMAN CEREBRAL-CORTEX; GRAY-MATTER; BRAIN; PROGRANULIN; HYPERINTENSITIES; DEGENERATION; INTEGRITY; ATROPHY; GENFI;
D O I
10.1093/braincomms/fcac333
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Lee et al. report that MRI-based white-matter abnormalities are more pronounced in presymptomatic GRN and C9orf72 mutation carriers, compared with family controls who do not carry the mutations. They suggest that white-matter changes may represent early markers of familial frontotemporal dementia associated with a genetic cause. A large proportion of familial frontotemporal dementia is caused by TAR DNA-binding protein 43 (transactive response DNA-binding protein 43 kDa) proteinopathies. Accordingly, carriers of autosomal dominant mutations in the genes associated with TAR DNA-binding protein 43 aggregation, such as Chromosome 9 open reading frame 72 (C9orf72) or progranulin (GRN), are at risk of later developing frontotemporal dementia. Brain imaging abnormalities that develop before dementia onset in mutation carriers may serve as proxies for the presymptomatic stages of familial frontotemporal dementia due to a genetic cause. Our study objective was to investigate brain MRI-based white-matter changes in predementia participants carrying mutations in C9orf72 or GRN genes. We analysed mutation carriers and their family member controls (noncarriers) from the University of British Columbia familial frontotemporal dementia study. First, a total of 42 participants (8 GRN carriers; 11 C9orf72 carriers; 23 noncarriers) had longitudinal T-1-weighted MRI over similar to 2 years. White-matter signal hypointensities were segmented and volumes were calculated for each participant. General linear models were applied to compare the baseline burden and the annualized rate of accumulation of signal abnormalities among mutation carriers and noncarriers. Second, a total of 60 participants (9 GRN carriers; 17 C9orf72 carriers; 34 noncarriers) had cross-sectional diffusion tensor MRI available. For each participant, we calculated the average fractional anisotropy and mean, radial and axial diffusivity parameter values within the normal-appearing white-matter tissues. General linear models were applied to compare whether mutation carriers and noncarriers had different trends in diffusion tensor imaging parameter values as they neared the expected age of onset. Baseline volumes of white-matter signal abnormalities were not significantly different among mutation carriers and noncarriers. Longitudinally, GRN carriers had significantly higher annualized rates of accumulation (estimated mean: 15.87%/year) compared with C9orf72 carriers (3.69%/year) or noncarriers (2.64%/year). A significant relationship between diffusion tensor imaging parameter values and increasing expected age of onset was found in the periventricular normal-appearing white-matter region. Specifically, GRN carriers had a tendency of a faster increase of mean and radial diffusivity values and C9orf72 carriers had a tendency of a faster decline of fractional anisotropy values as they reached closer to the expected age of dementia onset. These findings suggest that white-matter changes may represent early markers of familial frontotemporal dementia due to genetic causes. However, GRN and C9orf72 mutation carriers may have different mechanisms leading to tissue abnormalities.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Genetic modifiers in carriers of repeat expansions in the C9ORF72 gene
    Marka van Blitterswijk
    Bianca Mullen
    Aleksandra Wojtas
    Michael G Heckman
    Nancy N Diehl
    Matthew C Baker
    Mariely DeJesus-Hernandez
    Patricia H Brown
    Melissa E Murray
    Ging-Yuek R Hsiung
    Heather Stewart
    Anna M Karydas
    Elizabeth Finger
    Andrew Kertesz
    Eileen H Bigio
    Sandra Weintraub
    Marsel Mesulam
    Kimmo J Hatanpaa
    Charles L White
    Manuela Neumann
    Michael J Strong
    Thomas G Beach
    Zbigniew K Wszolek
    Carol Lippa
    Richard Caselli
    Leonard Petrucelli
    Keith A Josephs
    Joseph E Parisi
    David S Knopman
    Ronald C Petersen
    Ian R Mackenzie
    William W Seeley
    Lea T Grinberg
    Bruce L Miller
    Kevin B Boylan
    Neill R Graff-Radford
    Bradley F Boeve
    Dennis W Dickson
    Rosa Rademakers
    Molecular Neurodegeneration, 9
  • [42] Neuroimaging features of C9ORF72 expansion
    Yokoyama, Jennifer S.
    Rosen, Howard J.
    ALZHEIMERS RESEARCH & THERAPY, 2012, 4 (06):
  • [43] Distinct neural signatures of pulvinar in C9orf72 amyotrophic lateral sclerosis mutation carriers and noncarriers
    Nigri, Anna
    Stanziano, Mario
    Fedeli, Davide
    Manera, Umberto
    Ferraro, Stefania
    Carrion, Jean Paul Medina
    Palermo, Sara
    Lequio, Laura
    Denegri, Federica
    Agosta, Federica
    Spinelli, Edoardo Gioele
    Filippi, Massimo
    Grisoli, Marina
    Valentini, Maria Consuelo
    De Mattei, Filippo
    Canosa, Antonio
    Calvo, Andrea
    Chio, Adriano
    Bruzzone, Maria Grazia
    Moglia, Cristina
    EUROPEAN JOURNAL OF NEUROLOGY, 2024, 31 (06)
  • [44] Disrupted myelin lipid metabolism differentiates frontotemporal dementia caused by GRN and C9orf72 gene mutations
    Marian, Oana C.
    Teo, Jonathan D.
    Lee, Jun Yup
    Song, Huitong
    Kwok, John B.
    Landin-Romero, Ramon
    Halliday, Glenda
    Don, Anthony S.
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2023, 11 (01)
  • [45] The C9ORF72 mutation brings more answers and more questions
    Miller, Bruce L.
    ALZHEIMERS RESEARCH & THERAPY, 2013, 5 (01):
  • [46] Novel clinical associations with specific C9ORF72 transcripts in patients with repeat expansions in C9ORF72
    Marka van Blitterswijk
    Tania F. Gendron
    Matthew C. Baker
    Mariely DeJesus-Hernandez
    NiCole A. Finch
    Patricia H. Brown
    Lillian M. Daughrity
    Melissa E. Murray
    Michael G. Heckman
    Jie Jiang
    Clotilde Lagier-Tourenne
    Dieter Edbauer
    Don W. Cleveland
    Keith A. Josephs
    Joseph E. Parisi
    David S. Knopman
    Ronald C. Petersen
    Leonard Petrucelli
    Bradley F. Boeve
    Neill R. Graff-Radford
    Kevin B. Boylan
    Dennis W. Dickson
    Rosa Rademakers
    Acta Neuropathologica, 2015, 130 : 863 - 876
  • [47] The Phenotype of the C9ORF72 Expansion Carriers According to Revised Criteria for bvFTD
    Solje, Eino
    Aaltokallio, Heidi
    Koivumaa-Honkanen, Heli
    Suhonen, Noora M.
    Moilanen, Virpi
    Kiviharju, Anna
    Traynor, Bryan
    Tienari, Pentti J.
    Hartikainen, Paivi
    Remes, Anne M.
    PLOS ONE, 2015, 10 (07):
  • [48] Extensive transcriptomic study emphasizes importance of vesicular transport in C9orf72 expansion carriers
    Dickson, Dennis W.
    Baker, Matthew C.
    Jackson, Jazmyne L.
    DeJesus-Hernandez, Mariely
    Finch, NiCole A.
    Tian, Shulan
    Heckman, Michael G.
    Pottier, Cyril
    Gendron, Tania F.
    Murray, Melissa E.
    Ren, Yingxue
    Reddy, Joseph S.
    Graff-Radford, Neill R.
    Boeve, Bradley F.
    Petersen, Ronald C.
    Knopman, David S.
    Josephs, Keith A.
    Petrucelli, Leonard
    Oskarsson, Bjorn
    Sheppard, John W.
    Asmann, Yan W.
    Rademakers, Rosa
    van Blitterswijk, Marka
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2019, 7 (01)
  • [49] Brain morphologic changes in asymptomatic C9orf72 repeat expansion carriers
    Walhout, Renee
    Schmidt, Ruben
    Westeneng, Henk-Jan
    Verstraete, Esther
    Seelen, Meinie
    van Rheenen, Wouter
    de Reus, Marcel A.
    van Es, Michael A.
    Hendrikse, Jeroen
    Veldink, Jan H.
    van den Heuvel, Martijn P.
    van den Berg, Leonard H.
    NEUROLOGY, 2015, 85 (20) : 1780 - 1788
  • [50] C9orf72 intermediate repeats are associated with corticobasal degeneration, increased C9orf72 expression and disruption of autophagy
    Cali, Christopher P.
    Patino, Maribel
    Tai, Yee Kit
    Ho, Wan Yun
    McLean, Catriona A.
    Morris, Christopher M.
    Seeley, William W.
    Miller, Bruce L.
    Gaig, Carles
    Vonsattel, Jean Paul G.
    White, Charles L., III
    Roeber, Sigrun
    Kretzschmar, Hans
    Troncoso, Juan C.
    Troakes, Claire
    Gearing, Marla
    Ghetti, Bernardino
    Van Deerlin, Vivianna M.
    Lee, Virginia M-Y
    Trojanowski, John Q.
    Mok, Kin Y.
    Ling, Helen
    Dickson, Dennis W.
    Schellenberg, Gerard D.
    Ling, Shuo-Chien
    Lee, Edward B.
    ACTA NEUROPATHOLOGICA, 2019, 138 (05) : 795 - 811